158 related articles for article (PubMed ID: 28516744)
21. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
Kwon YN; Woodhall M; Sung JJ; Kim KK; Lim YM; Kim H; Kim JE; Baek SH; Kim BJ; Park JS; Seok HY; Kim DS; Kwon O; Park KH; Sohn E; Bae JS; Yoon BN; Kim NH; Ahn SW; Choi K; Oh J; Park HJ; Shin KJ; Lee S; Park J; Kim SH; Seok JI; Bae DW; An JY; Joo IS; Choi SJ; Nam TS; Kim S; Park KJ; Kwon KH; Waters P; Hong YH
J Neurol; 2023 Mar; 270(3):1478-1486. PubMed ID: 36396811
[TBL] [Abstract][Full Text] [Related]
22. Different characteristic phenotypes according to antibody in myasthenia gravis.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
[TBL] [Abstract][Full Text] [Related]
23. The accessory nerve repetitive nerve stimulation test: a valuable second-line test in myasthenia gravis.
Claussen GC; Fesenmeier JT; Hah JS; Brooks J; Oh SJ
Eur J Neurol; 1995 Nov; 2(5):492-7. PubMed ID: 24283732
[TBL] [Abstract][Full Text] [Related]
24. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
Konishi T
Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139
[TBL] [Abstract][Full Text] [Related]
25. Repetitive hypoglossal nerve stimulation in myasthenia gravis.
Lo YL; Leoh TH; Tan YE; Foo ML; Dan YF; Ratnagopal P
Clin Neurophysiol; 2002 Aug; 113(8):1227-30. PubMed ID: 12140000
[TBL] [Abstract][Full Text] [Related]
26. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
27. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
[TBL] [Abstract][Full Text] [Related]
28. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
[TBL] [Abstract][Full Text] [Related]
29. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
[TBL] [Abstract][Full Text] [Related]
30. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.
Oh SJ
J Clin Neurol; 2009 Jun; 5(2):53-64. PubMed ID: 19587811
[TBL] [Abstract][Full Text] [Related]
31. Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.
Muppidi S; Wolfe GI
Front Neurol Neurosci; 2009; 26():109-119. PubMed ID: 19349708
[TBL] [Abstract][Full Text] [Related]
32. Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study.
Zhao S; Zhang K; Ren K; Lu J; Ma C; Zhao C; Li Z; Guo J
BMC Neurol; 2021 Nov; 21(1):428. PubMed ID: 34732168
[TBL] [Abstract][Full Text] [Related]
33. Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.
He T; Chen K; Li Y; Luo Z; Luo M; Yang H
Neuropsychiatr Dis Treat; 2024; 20():725-735. PubMed ID: 38566882
[TBL] [Abstract][Full Text] [Related]
34. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
[TBL] [Abstract][Full Text] [Related]
35. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
Farrugia ME; Kennett RP; Newsom-Davis J; Hilton-Jones D; Vincent A
Muscle Nerve; 2006 Apr; 33(4):568-70. PubMed ID: 16382443
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
37. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
38. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity.
Shin HY; Park HJ; Lee HE; Choi YC; Kim SM
J Clin Neurol; 2014 Apr; 10(2):119-24. PubMed ID: 24829597
[TBL] [Abstract][Full Text] [Related]
40. Antibody profile may predict outcome in ocular myasthenia gravis.
Galassi G; Mazzoli M; Ariatti A; Kaleci S; Valzania F; Nichelli PF
Acta Neurol Belg; 2018 Sep; 118(3):435-443. PubMed ID: 29858757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
